Waleed Th. Aletreby

“Ventilator-free days” composite outcome in patients with SARS-CoV-2 infection treated with tocilizumab: A retrospective competing risk analysis

A. Alharthy, A. Mady, S. Mumtaz, 2022, Heart & Lung.

Tracheostomy as an Independent Risk Factor of ICU Readmission

O. Ramadan, S. Mumtaz, M. Al-Odat, 2017 .

Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis

A. Alharthy, D. Karakitsos, A. Mady, 2021, medRxiv.